Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Depreciation & Amortization (IS): 2011-2017

Historic Depreciation & Amortization (IS) for Arrowhead Pharmaceuticals (ARWR) over the last 6 years, with Dec 2017 value amounting to $1.1 million.

  • Arrowhead Pharmaceuticals' Depreciation & Amortization (IS) fell 3.75% to $1.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $4.6 million, marking a year-over-year increase of 27.24%. This contributed to the annual value of $4.7 million for FY2017, which is 43.88% up from last year.
  • As of Q4 2017, Arrowhead Pharmaceuticals' Depreciation & Amortization (IS) stood at $1.1 million, which was down 1.16% from $1.2 million recorded in Q3 2017.
  • Arrowhead Pharmaceuticals' Depreciation & Amortization (IS)'s 5-year high stood at $9.2 million during Q3 2013, with a 5-year trough of $276,054 in Q2 2014.
  • In the last 3 years, Arrowhead Pharmaceuticals' Depreciation & Amortization (IS) had a median value of $849,568 in 2015 and averaged $928,152.
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Depreciation & Amortization (IS) soared by 1,948.60% in 2013, and later crashed by 39.21% in 2014.
  • Arrowhead Pharmaceuticals' Depreciation & Amortization (IS) (Quarterly) stood at $403,405 in 2013, then fell by 28.10% to $290,039 in 2014, then surged by 173.88% to $794,349 in 2015, then soared by 49.26% to $1.2 million in 2016, then decreased by 3.75% to $1.1 million in 2017.
  • Its last three reported values are $1.1 million in Q4 2017, $1.2 million for Q3 2017, and $1.2 million during Q2 2017.